Familial Cancer

1.9(top 20%)

impact factor

1.4K(top 20%)

papers

27.7K(top 10%)

citations

68(top 10%)

h-index

2.0(top 20%)

impact factor

1.5K

all documents

29.1K

doc citations

98(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Attenuated familial adenomatous polyposis (AFAP). A review of the literature	Familial Cancer	2003	253
2	Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations	Familial Cancer	2012	252
3	Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment	Familial Cancer	2014	251
4	Lynch Syndrome Genes	Familial Cancer	2005	219
5	Current ideas in desmoid tumours	Familial Cancer	2006	209
6	Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management	Familial Cancer	2008	187
7	Cancer risk in Lynch Syndrome	Familial Cancer	2013	186
8	Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis	Familial Cancer	2009	185
9	Promoter Hypermethylation Frequency and BRAF Mutations Distinguish Hereditary Non-Polyposis Colon Cancer from Sporadic MSI-H Colon Cancer	Familial Cancer	2002	177
10	The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedside	Familial Cancer	2008	163
11	Paragangliomas of the head and neck: diagnosis and treatment	Familial Cancer	2005	155
12	The Incidence of Lynch Syndrome	Familial Cancer	2005	154
13	Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer	Familial Cancer	2007	153
14	Imaging of pheochromocytoma and paraganglioma	Familial Cancer	2005	140
15	HNPCC and Sporadic MSI-H Colorectal Cancer: A Review of the Morphological Similarities and Differences	Familial Cancer	2002	138
16	German national case collection for familial pancreatic cancer (FaPaCa): ten years experience	Familial Cancer	2011	129
17	BRCA1 and BRCA2: Chemosensitivity, Treatment Outcomes and Prognosis	Familial Cancer	2006	128
18	Update on Lynch syndrome genomics	Familial Cancer	2016	127
19	Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)	Familial Cancer	2008	123
20	Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics	Familial Cancer	2011	121
21	Update multiple endocrine neoplasia type 2	Familial Cancer	2010	120
22	Pancreatic cancer and the FAMMM syndrome	Familial Cancer	2008	119
23	Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome	Familial Cancer	2014	119
24	Evolution of the Nomenclature for the Hereditary Colorectal Cancer Syndromes	Familial Cancer	2005	118
25	Hereditary diffuse gastric cancer: association with lobular breast cancer	Familial Cancer	2008	117
26	Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors	Familial Cancer	2013	115
27	Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited	Familial Cancer	2006	111
28	Use of Microsatellite Instability and Immunohistochemistry Testing for the Identification of Individuals at Risk for Lynch Syndrome	Familial Cancer	2005	109
29	Communicating genetic risk information within families: a review	Familial Cancer	2010	106
30	Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer	Familial Cancer	2001	105
31	Mitochondrial membrane potential and reactive oxygen species in cancer stem cells	Familial Cancer	2015	105
32	High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine	Familial Cancer	2016	105
33	Recommendations to improve identification of hereditary and familial colorectal cancer in Europe	Familial Cancer	2010	103
34	PALB2 mutations in familial breast and pancreatic cancer	Familial Cancer	2011	102
35	A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han	Familial Cancer	2010	101
36	EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients	Familial Cancer	2013	100
37	The InSiGHT database: utilizing 100 years of insights into Lynch Syndrome	Familial Cancer	2013	100
38	Pulmonary manifestations of Birt-Hogg-Dubé syndrome	Familial Cancer	2013	100
39	CDH1 germline mutations and hereditary lobular breast cancer	Familial Cancer	2016	99
40	Syndrome of Early Onset Colon Cancers, Hematologic Malignancies & Features of Neurofibromatosis in HNPCC Families with Homozygous Mismatch Repair Gene Mutations	Familial Cancer	2005	97
41	The genetics of FAP and FAP-like syndromes	Familial Cancer	2006	97
42	Desmoid Tumors – a Characterization of Patients Seen at Mayo Clinic 1976–1999	Familial Cancer	2006	97
43	Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer	Familial Cancer	2013	97
44	The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis	Familial Cancer	2013	94
45	Cancer variation associated with the position of the mutation in the BRCA2 gene	Familial Cancer	2002	91
46	Clinical Description of the Lynch Syndrome [Hereditary Nonpolyposis Colorectal Cancer (HNPCC)]	Familial Cancer	2005	91
47	Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis	Familial Cancer	2006	91
48	Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry	Familial Cancer	2013	88
49	The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study	Familial Cancer	2001	87
50	Guidelines for Disclosing Genetic Information to Family Members: From Development to Use	Familial Cancer	2006	87

Scientometrics

Overviews

Citing Bodies

Familial Cancer

Top Articles